GLOW ProtocolSkin / hair / tissue research blendBlendSafety Rating 8/10
Price Comparison
Compare vendors
Research details
GLOW Protocol — research data
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Overview
About GLOW Protocol
Mechanism of action
Fixed-ratio combination of three regenerative peptides: BPC-157 (anti-inflammatory, tissue repair), TB-500 (angiogenesis and cell migration), and GHK-Cu (collagen/elastin synthesis, copper delivery). Effects derive from the individual components rather than any proven synergy.
Safety profile
Injection-site reactions; temporary blue-green skin discoloration (copper); water retention; the main risk is overdosing an individual component in a fixed-ratio blend. Research-use only; not for human consumption. · Marketed blend (GHK-Cu + BPC-157 + TB-500); well-tolerated components, but no combination-specific trials. Fixed-ratio dosing means a component can fall outside its range; the BPC-157/TB-500 pair is pro-angiogenic (cancer contraindication). Components not FDA-approved.
Storage
Stability & handling
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops GLOW Protocol below your target.
Blend
Component Compounds
BPC-157
VEGFR2/angiogenesis, GI protection
TB-500
Actin binding, cell migration, anti-inflammatory
GHK-Cu
Collagen synthesis, antioxidant, wound healing
Related pages
More on GLOW Protocol
Stack & Compare
Frequently Researched Together
Research
Studies & key findings
- GLOW is a fixed-ratio COMBINATION (BPC-157 + TB-500 + GHK-Cu), not a single compound — its evidence base is the individual components, and there is little formal research on the fixed-ratio blend itself.
- GHK-Cu carries the strongest skin-rejuvenation evidence of the three (collagen and elastin synthesis), but almost entirely from TOPICAL studies rather than injection.